![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Vries, Rory D. de; Altenburg, Arwen F.; Nieuwkoop, Nella J.; Bruin, Erwin de; Trierum, Stella E. van; Pronk, Mark R.; Lamers, Mart M.; Richard, Mathilde; Nieuwenhuijse, David F.; Koopmans, Marion P. G.; Kreijtz, Joost H. C. M.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Sutter, Gerd 
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2018):
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
In: Journal of Infectious Diseases, Bd. 218, Nr. 4: S. 614-623
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2018):
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
In: Journal of Infectious Diseases, Bd. 218, Nr. 4: S. 614-623
Altenburg, Arwen F.; Kreijtz, Joost H. C. M.; de Vries, Rory D.; Song, Fei; Fux, Robert; Rimmelzwaan, Guus F.; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(Juli 2014):
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.
In: Viruses, Bd. 6, Nr. 7: S. 2735-2761
[PDF, 847kB]
ORCID: https://orcid.org/0000-0001-6143-082X und Volz, Asisa
(Juli 2014):
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.
In: Viruses, Bd. 6, Nr. 7: S. 2735-2761
[PDF, 847kB]
Kreijtz, Joost H. C. M.; Suezer, Yasemin; Mutsert, Gerrie de; Amerongen, Geert van; Schwantes, Astrid; Brand, Judith M. A. van den; Fouchier, Ron A. M.; Löwer, Johannes; Osterhaus, Albert D. M. E.; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2009):
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
In: PLOS ONE 4(11), e7790 [PDF, 925kB]
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2009):
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
In: PLOS ONE 4(11), e7790 [PDF, 925kB]